BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20100953)

  • 21. Sharing scientific data I: new problems for IRBs.
    Sieber JE
    IRB; 1989; 11(6):4-7. PubMed ID: 11650286
    [No Abstract]   [Full Text] [Related]  

  • 22. U.S. election. McCain, Obama present their wars on cancer.
    Couzin J
    Science; 2008 Sep; 321(5895):1432. PubMed ID: 18787141
    [No Abstract]   [Full Text] [Related]  

  • 23. Practical tips for working effectively with your institutional review board.
    Schwenzer KJ
    Respir Care; 2008 Oct; 53(10):1354-61. PubMed ID: 18812000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The difficulties and costs of ethical assessment of a national research project.
    Dockerty JD; Elwood M
    N Z Med J; 1992 Aug; 105(939):311-3. PubMed ID: 1501815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NIH cancer chief wants more with less: by Meredith Wadman.
    Varmus H
    Nature; 2011 Jul; 475(7354):18. PubMed ID: 21734681
    [No Abstract]   [Full Text] [Related]  

  • 26. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer Research and the OCCAM.
    Smith W
    Explore (NY); 2007; 3(4):396-403. PubMed ID: 17681261
    [No Abstract]   [Full Text] [Related]  

  • 28. A central institutional review board for multi-institutional trials.
    Christian MC; Goldberg JL; Killen J; Abrams JS; McCabe MS; Mauer JK; Wittes RE
    N Engl J Med; 2002 May; 346(18):1405-8. PubMed ID: 11986418
    [No Abstract]   [Full Text] [Related]  

  • 29. US bioethics panel poised to judge local review boards.
    Macilwain C
    Nature; 1996 Oct; 383(6600):466. PubMed ID: 8849708
    [No Abstract]   [Full Text] [Related]  

  • 30. Rules of the game: institutional review boards.
    Lubowitz JH; Poehling GG; Burkhart SS
    Arthroscopy; 2008 Apr; 24(4):373-4. PubMed ID: 18375265
    [No Abstract]   [Full Text] [Related]  

  • 31. Overseeing research on therapeutic cloning: a private ethics board responds to its critics.
    Green RM; DeVries KO; Bernstein J; Goodman KW; Kaufmann R; Kiessling AA; Levin SR; Moss SL; Tauer CA
    Hastings Cent Rep; 2002; 32(3):27-33. PubMed ID: 12085512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A higher standard for human research.
    Nat Med; 1999 Jun; 5(6):591. PubMed ID: 10371478
    [No Abstract]   [Full Text] [Related]  

  • 33. NCI's clinical trial system: efficiencies grow, debate goes on.
    Nicholas J
    J Natl Cancer Inst; 2010 Dec; 102(23):1750-1, 1755. PubMed ID: 21088280
    [No Abstract]   [Full Text] [Related]  

  • 34. Institutional review boards and financial conflicts of interest.
    Maloney DM
    Hum Res Rep; 2002 Feb; 17(2):1-2. PubMed ID: 12374174
    [No Abstract]   [Full Text] [Related]  

  • 35. The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.
    Diamond MP; Eisenberg E; Huang H; Coutifaris C; Legro RS; Hansen KR; Steiner AZ; Cedars M; Barnhart K; Ziolek T; Thomas TR; Maurer K; Krawetz SA; Wild RA; Trussell JC; Santoro N; Zhang H;
    Clin Trials; 2019 Feb; 16(1):3-10. PubMed ID: 30354458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Worker notification and institutional review for privately funded research in occupational health and safety.
    American Public Health Association
    Am J Public Health; 1996 Mar; 86(3):432-3. PubMed ID: 11644772
    [No Abstract]   [Full Text] [Related]  

  • 37. Dilemmas in paying for clinical research: the view from the IRB.
    Lind SE
    IRB; 1987; 9(2):1-5. PubMed ID: 11649900
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematopoietic stem cell transplant research with pediatric donors: when can institutional review boards approve it?
    Peerzada JM; Wendler D
    Transplantation; 2006 Jun; 81(12):1616-20. PubMed ID: 16794524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of institutional review boards in academic medical centers.
    Sugarman J; Getz K; Speckman JL; Byrne MM; Gerson J; Emanuel EJ;
    N Engl J Med; 2005 Apr; 352(17):1825-7. PubMed ID: 15858200
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer research and the $90 billion metaphor.
    Marshall E
    Science; 2011 Mar; 331(6024):1540-1. PubMed ID: 21436436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.